SEOM–SERAM–SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer

• G. Fernández-Pérez ^[1] ; R. Sánchez-Escribano ^[2] ; A. M. García-Vicente ^[6] ; A. Luna-Alcalá ^[7] ; J. Ceballos-Viro ^[8] ; R. C. Delgado-Bolton ^[3] ; J. C. Vilanova-Busquets ^[9] ; P. Sánchez-Rovira ^[4] ; M. P. Fierro-Alanis ^[5] ; R. García-Figueiras ^[10] ; J. E. Alés-Martínez ^[8]
  1. [1] Hospital Universitario Pío del Río Hortega

     Hospital Universitario Pío del Río Hortega

     Valladolid, España

     
  2. [2] Complejo Asistencial Universitario de Burgos

     Complejo Asistencial Universitario de Burgos

     Burgos, España

     
  3. [3] Hospital San Pedro

     Hospital San Pedro

     Logroño, España

     
  4. [4] Hospital Universitario de Jaén

     Hospital Universitario de Jaén

     Jaén, España

     
  5. [5] Complexo Hospitalario Universitario de Santiago

     Complexo Hospitalario Universitario de Santiago

     Santiago de Compostela, España

     
  6. [6] Hospital Gneeral Universitario de Ciudad Real, España
  7. [7] Clínica Las Nieves Jaén, España
  8. [8] Hospital Nuestra Señora de Sonsoles, España
  9. [9] Instituto Catalán de Salud, España
  10. [10] Complexo Hospitalario Santiago de Compostela, España

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 20, Nº. 7 (July 2018), 2018, págs. 837-852
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Imaging in oncology is an essential tool for patient management but its potential is being profoundly underutilized. Each of the techniques used in the diagnostic process also conveys functional information that can be relevant in treatment decision-making. New imaging algorithms and techniques enhance our knowledge about the phenotype of the tumor and its potential response to different therapies. Functional imaging can be defined as the one that provides information beyond the purely morphological data, and include all the techniques that make it possible to measure specific physiological functions of the tumor, whereas molecular imaging would include techniques that allow us to measure metabolic changes. Functional and molecular techniques included in this document are based on multi-detector computed tomography (CT), 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET), magnetic resonance imaging (MRI), and hybrid equipments, integrating PET with CT (PET/CT) or MRI (PET-MRI). Lung cancer is one of the most frequent and deadly tumors although survival is increasing thanks to advances in diagnostic methods and new treatments. This increased survival poises challenges in terms of proper follow-up and definitions of response and progression, as exemplified by immune therapy-related pseudoprogression. In this consensus document, the use of functional and molecular imaging techniques will be addressed to exploit their current potential and explore future applications in the diagnosis, evaluation of response and detection of recurrence of advanced NSCLC.